2008
DOI: 10.1128/cmr.00006-08
|View full text |Cite
|
Sign up to set email alerts
|

Polymyxins Revisited

Abstract: SUMMARY The global emergence of multidrug-resistant gram-negative bacilli has spurred a renewed interest in polymyxins. Once discarded due to concerns regarding nephrotoxicity and neurotoxicity, polymyxins now hold an important role in the antibiotic armamentarium. However, more reliable information is needed to determine the optimal dosing of these agents. Also, unanswered questions regarding in vitro testing remain, including questions regarding the reliability of automated systems and the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
463
1
8

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 538 publications
(492 citation statements)
references
References 167 publications
5
463
1
8
Order By: Relevance
“…This lack of new antimicrobials to replace those that become ineffective brings added urgency to the need to protect the efficacy of existing drugs. In the last few years there has been a resurgence of old antibiotics, and specially polymyxins discovered in the 1940s [6], as drugs of last resort for the treatment of infections caused by multi-drug resistant Gram-negative pathogens, despite their toxicity (nephro-and neurotoxicity) and the lack of clinical efficacy data [7,8]. Polymyxins belong to the class of antimicrobial peptides (AMPs), a class of antibiotics that have attracted great interest in the last few years because they rarely spur the development of resistant organisms.…”
Section: Introductionmentioning
confidence: 99%
“…This lack of new antimicrobials to replace those that become ineffective brings added urgency to the need to protect the efficacy of existing drugs. In the last few years there has been a resurgence of old antibiotics, and specially polymyxins discovered in the 1940s [6], as drugs of last resort for the treatment of infections caused by multi-drug resistant Gram-negative pathogens, despite their toxicity (nephro-and neurotoxicity) and the lack of clinical efficacy data [7,8]. Polymyxins belong to the class of antimicrobial peptides (AMPs), a class of antibiotics that have attracted great interest in the last few years because they rarely spur the development of resistant organisms.…”
Section: Introductionmentioning
confidence: 99%
“…(26,27) Unfortunately, there is very limited clinical experience regarding the treatment of patients infected with carbapenemase producing Enterobacteriaceae. (28) Only two classes of drugs, polymyxins and glycylcyclines have shown to have good in vitro activity against NDM-1 producers. (29) This may further lead us to reconsider the potential role of gene mutations in Class 1 integrons that may be involved in developing multi-drug resistance or even extremely drug resistant bacterial strains.…”
Section: Introductionmentioning
confidence: 99%
“…It is currently reserved for the treatment of multiresistant bacteria to other antibiotics (4)(5)(6) .…”
Section: Introductionmentioning
confidence: 99%